financetom
SEM
financetom
/
Healthcare
/
SEM
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
Select Medical Holdings CorporationSEM
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
% Change
Description >

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States.

It operates through four segments: The Critical Illness Recovery Hospital, The Rehabilitation Hospital, The Outpatient Rehabilitation, and The Concentra.

The company's Critical Illness Recovery Hospital segment consists of hospitals that provide services for heart failure, infectious disease, respiratory failure and pulmonary disease, surgery requiring prolonged recovery, renal disease, neurological events, and trauma.

Its Rehabilitation Hospital segment offers therapy and rehabilitation treatments, including rehabilitative services for brain and spinal cord injuries, strokes, amputations, neurological disorders, orthopedic conditions, pediatric congenital or acquired disabilities, and cancer.

The company's Outpatient Rehabilitation segment operates rehabilitation clinics that provide physical, occupational, and speech rehabilitation programs and services; and specialized programs, such as functional programs for work related injuries, hand therapy, post-concussion rehabilitation, pediatric and cancer rehabilitation, and athletic training services.

Its Concentra segment operates and provides occupational health centers and contract services at employer worksites that deliver occupational medicine, consumer health, physical therapy, and wellness services.

Select Medical Holdings Corporation was founded in 1996 and is headquartered in Mechanicsburg, Pennsylvania.

Latest News >
Structure Therapeutics' obesity drug meets main goal in mid-stage study
Structure Therapeutics' obesity drug meets main goal in mid-stage study
Jun 3, 2024
June 3 (Reuters) - Structure Therapeutics ( GPCR ) said on Monday its obesity drug candidate met the main goal in a mid-stage study. (Reporting by Mariam Sunny in Bengaluru; Editing by Devika Syamnath) ...
Science Applications International Fiscal Q1 Adjusted Earnings, Revenue Decline; Fiscal 2025 Guidance Reiterated
Science Applications International Fiscal Q1 Adjusted Earnings, Revenue Decline; Fiscal 2025 Guidance Reiterated
Jun 3, 2024
07:40 AM EDT, 06/03/2024 (MT Newswires) -- Science Applications International ( SAIC ) reported fiscal Q1 adjusted earnings Monday of $1.92 per diluted share, down from $2.14 a year earlier. Analysts polled by Capital IQ expected $1.92. Revenue for the fiscal quarter ended May 3 was $1.85 billion, down from $2.03 billion a year earlier. Analysts surveyed by Capital IQ...
Update: Generation Mining Applauds International Energy Forum Report Outlining EV Copper Hurdles
Update: Generation Mining Applauds International Energy Forum Report Outlining EV Copper Hurdles
Jun 3, 2024
07:37 AM EDT, 06/03/2024 (MT Newswires) -- Generation Mining ( GENMF ) on Monday cheered a recent report by the International Energy Forum outlining rising global demand for copper amid the energy transition. The report, titled Copper Mining and Vehicle Electrification, found that the world will not be able to produce enough copper to transition to 100% electric vehicle production...
Market Chatter: Blackstone Considering Sale of Alinamin Pharmaceutical
Market Chatter: Blackstone Considering Sale of Alinamin Pharmaceutical
Jun 3, 2024
07:32 AM EDT, 06/03/2024 (MT Newswires) -- Blackstone (BX) is exploring the sale of Alinamin Pharmaceutical Co., a Japanese consumer healthcare firm previously owned by Takeda Pharmaceutical Co. for around 300 billion yen ($1.9 billion), Bloomberg reported on Monday, citing people familiar with the situation. Interest in Alinamin has been expressed by investment firms such as CVC Capital Partners Plc,...
Copyright 2023-2025 - www.financetom.com All Rights Reserved